Dynamics of visual acuity, optical coherence tomography (OСT) and OСT angiography indicators of patients with dry form of age-related macular degeneration using double filtration plasmapheresis

Purpose: to study the structural and functional changes in the macular zone in patients with dry age-related macular degeneration (dAMD) according to optical coherence tomography (OCT), OCT angiography (OCTA) and visometry after the use of cascade plasma filtration. Materials and methods. A total of 63 patients (94 eyes) with intermediate-stage sAMD were randomly divided into two groups. Group 1 (main) included 34 patients (52 eyes) who underwent 4 cascade plasmafiltration (CPF) procedures on the OctoNova device using the Plasmaflo plasma filter and the Cascadeflo EC40 fractionator once a week for 1 month. Group 2 (control) included 29 patients (42 eyes) who did not receive any specific treatment. Patients of the main group underwent OCT and OCTA along with a standard ophthalmological examination before the CPF course, as well as after it (1 month from the start of observation), 6 and 12 months after treatment. Patients of the control group also underwent a similar examination at the specified times — 1, 6, 12 months from the start of follow-up. Results. According to OCT, OCTA and visometry data, positive dynamics of structural and functional indices of the macular retina are observed in patients with sAMD after CPF. At the same time, a statistically significant difference between the two groups is noted starting from the first month and persists for 12 months of follow-up, which indicates stabilization of the pathological process during the specified period. Conclusion. OCT, OCTA and visometry data demonstrate improvement of the structural and functional indices of the macular zone in patients with sAMD after the use of CPF. A decrease in the risk of disease progression to a late stage and stabilization of visual functions are noted. In our study, the positive effect of the CPF persisted for 12 months, however, obviously, the positive result of the procedure is temporary, which justifies the need for further observations to determine the optimal timing of repeated courses.

1. Izmaylov A.S. Treatment of a “dry” form of age-related macular degeneration. RMJ “Klinicheskaya ophtalmologia”. 2017; 1: 56–60 (In Russ.). doi: 10.21689/2311-7729-2017-17-1-56-60

2. Donders FC. Beiträge zur pathologischen Anatomie des Auges. Albrecht von Graefes Archiv für Ophthalmologie. 1857; 3 (1): 139–65. https://doi.org/10.1007/BF02720685

3. Hutchinson J. Symmetrical central choroido-retinal disease occurring in senile persons. The Royal London Ophthalmic Hospital records and journal of ophthalmic medicine and surgery. 1874; 231–44.

4. Haab O. Erkrankungen der Macula Lutea. Centralblatt für praktische Augenheilkunde. 1885; 383–4.

5. Haab O. Atlas und Grundriss der Ophthalmoskopie und ophthalmoskopischen Diagnostik. Atlas and outline of ophthalmoscopy and ophthalmoskopic diagnostics. Lehmann: München, 1908. https://wellcomecollection.org/works/vp57fvcq

6. Gass JD. Drusen and disciform macular detachment and degeneration. Arch Ophthalmol. 1973 Sep; 90 (3): 206–17. doi: 10.1001/archopht.1973.01000050208006

7. Liebman E.S., Shakhova E.V. Blindness and disability due to pathology of the organ of vision in Russia. Vestnik oftal’mologii. 2006; 122 (1): 209–14 (In Russ.).

8. Konyaev D.A., Popova E.V., Titov A.A., et al. The prevalence of eye diseases in the elderly population is a global problem of modernity. Health care of the Russian Federation. 2021; 65 (1): 62–8 (In Russ.). https://doi.org/10.47470/0044-197X-2021-65-1-62-68

9. Stahl A. The diagnosis and treatment of age-related macular degeneration. Dtsch Arztebl Int. 2020 Jul 20; 117 (29–30): 513-20. doi: 10.3238/arztebl.2020.0513

10. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014 Feb; 2 (2): e106-16. doi: 10.1016/S2214-109X(13)70145-1

11. Thomas CJ, Mirza RG, Gill MK. Age-Related Macular Degeneration. Med Clin North Am. 2021 May; 105 (3): 473–91. doi: 10.1016/j.mcna.2021.01.003

12. De Jong PTVM. Elusive drusen and changing terminology of AMD. Eye (Lond). 2018 May; 32(5): 904–14. doi: 10.1038/eye.2017.298

13. Manuilov A.S., Bardakov S.N., Apchel A.V., et al. The experience of using cascade plasmofiltration in combined treatment with systemic lupus erythematosus on the background of programmed hemodialysis. Bulletin of the Russian Military Medical Academy. 2018; 20 (2): 115–9 (In Russ.). doi: 10.17816/brmma12278

14. Chew EY, Clemons TE, Agrón E, et al; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1; 140 (7): 692–8. doi: 10.1001/jamaophthalmol.2022.1640

15. Brunner R, Widder RA, Walter P, et al. Influence of membrane differential filtration on the natural course of age-related macular degeneration: a randomized trial. Retina. 2000; 20 (5): 483–91. doi: 10.1097/00006982-200009000-00009

16. Swartz M, Rabetoy G. Treatment of non-exudative agerelated macular degeneration using membrane differential filtration apheresis [meeting abstract from the Association for Research in Vision and Ophthalmology annual meeting. Fort Lauderdale, Florida, USA. May 9–14, 1999]. Invest Ophthalmol Vis Sci. 1999; 40: S319.

17. Klingel R, Fassbender C, Heibges A, et al. RheoNet registry analysis of rheopheresis for microcirculatory disorders with a focus on age-related macular degeneration. Ther Apher Dial. 2010 Jun; 14 (3): 276–86. doi: 10.1111/j.1744-9987.2010.00807.x